PubRank

S J Galli

Author PubWeight™ 227.34‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983 15.43
2 Mast cells as a source of both preformed and immunologically inducible TNF-alpha/cachectin. Nature 1990 4.21
3 Inducer T lymphocytes synthesize a factor that stimulates proliferation of cloned mast cells. Nature 1981 3.71
4 Fate of bone marrow-derived cultured mast cells after intracutaneous, intraperitoneal, and intravenous transfer into genetically mast cell-deficient W/Wv mice. Evidence that cultured mast cells can give rise to both connective tissue type and mucosal mast cells. J Exp Med 1985 3.69
5 Interleukin 3-dependent and -independent mast cells stimulated with IgE and antigen express multiple cytokines. J Exp Med 1989 3.03
6 Role for interleukin-3 in mast-cell and basophil development and in immunity to parasites. Nature 1998 2.82
7 Pulmonary responses to bronchoconstrictor agonists in the mouse. J Appl Physiol (1985) 1988 2.64
8 IgE enhances mouse mast cell Fc(epsilon)RI expression in vitro and in vivo: evidence for a novel amplification mechanism in IgE-dependent reactions. J Exp Med 1997 2.48
9 Mast cells as a source of multifunctional cytokines. Immunol Today 1990 2.46
10 Mast cells can amplify airway reactivity and features of chronic inflammation in an asthma model in mice. J Exp Med 2000 2.46
11 Mouse splenic and bone marrow cell populations that express high-affinity Fc epsilon receptors and produce interleukin 4 are highly enriched in basophils. Proc Natl Acad Sci U S A 1991 2.41
12 Systemic anaphylaxis in the mouse can be mediated largely through IgG1 and Fc gammaRIII. Assessment of the cardiopulmonary changes, mast cell degranulation, and death associated with active or IgE- or IgG1-dependent passive anaphylaxis. J Clin Invest 1997 2.29
13 Release of both preformed and newly synthesized tumor necrosis factor alpha (TNF-alpha)/cachectin by mouse mast cells stimulated via the Fc epsilon RI. A mechanism for the sustained action of mast cell-derived TNF-alpha during IgE-dependent biological responses. J Exp Med 1991 2.21
14 Induction of mast cell proliferation, maturation, and heparin synthesis by the rat c-kit ligand, stem cell factor. Proc Natl Acad Sci U S A 1991 2.17
15 Induction of a fibrin-gel investment: an early event in line 10 hepatocarcinoma growth mediated by tumor-secreted products. J Immunol 1979 2.15
16 Recruitment of neutrophils during IgE-dependent cutaneous late phase reactions in the mouse is mast cell-dependent. Partial inhibition of the reaction with antiserum against tumor necrosis factor-alpha. J Clin Invest 1991 2.14
17 Regulation of mast cell survival by IgE. Immunity 2001 2.11
18 An unexpected version of horror autotoxicus: anaphylactic shock to a self-peptide. Nat Immunol 2001 2.10
19 Genetically mast-cell-deficient W/Wv and Sl/Sld mice. Their value for the analysis of the roles of mast cells in biologic responses in vivo. Am J Pathol 1987 2.05
20 Human eosinophils express transforming growth factor alpha. J Exp Med 1990 2.04
21 Identification of a committed precursor for the mast cell lineage. Science 1996 2.04
22 Roles of mast cells and basophils in innate and acquired immunity. Curr Opin Immunol 2000 2.02
23 Involvement of Bruton's tyrosine kinase in FcepsilonRI-dependent mast cell degranulation and cytokine production. J Exp Med 1998 1.99
24 Identification, purification, and characterization of a mast cell-associated cytolytic factor related to tumor necrosis factor. Proc Natl Acad Sci U S A 1987 1.96
25 Basophils and mast cells: morphologic insights into their biology, secretory patterns, and function. Prog Allergy 1984 1.94
26 Mast cell clones: a model for the analysis of cellular maturation. J Cell Biol 1982 1.91
27 The rat c-kit ligand, stem cell factor, induces the development of connective tissue-type and mucosal mast cells in vivo. Analysis by anatomical distribution, histochemistry, and protease phenotype. J Exp Med 1991 1.89
28 Mast cells can secrete vascular permeability factor/ vascular endothelial cell growth factor and exhibit enhanced release after immunoglobulin E-dependent upregulation of fc epsilon receptor I expression. J Exp Med 1998 1.84
29 Impaired mast cell-dependent natural immunity in complement C3-deficient mice. Nature 1997 1.78
30 The diverse potential effector and immunoregulatory roles of mast cells in allergic disease. J Allergy Clin Immunol 2000 1.76
31 Mast cell-dependent neutrophil and mononuclear cell recruitment in immunoglobulin E-induced gastric reactions in mice. Gastroenterology 1996 1.75
32 Rejection of first-set skin allografts in man. the microvasculature is the critical target of the immune response. J Exp Med 1979 1.74
33 The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils. J Immunol 1992 1.72
34 Mast cell-dependent amplification of an immunologically nonspecific inflammatory response. Mast cells are required for the full expression of cutaneous acute inflammation induced by phorbol 12-myristate 13-acetate. J Immunol 1988 1.67
35 Absence of Fc epsilonRI alpha chain results in upregulation of Fc gammaRIII-dependent mast cell degranulation and anaphylaxis. Evidence of competition between Fc epsilonRI and Fc gammaRIII for limiting amounts of FcR beta and gamma chains. J Clin Invest 1997 1.67
36 Role of mast cells in anaphylaxis. Evidence for the importance of mast cells in the cardiopulmonary alterations and death induced by anti-IgE in mice. J Clin Invest 1989 1.62
37 125I-fibrin deposition in IgE-dependent immediate hypersensitivity reactions in mouse skin. Demonstration of the role of mast cells using genetically mast cell-deficient mice locally reconstituted with cultured mast cells. J Immunol 1987 1.58
38 The c-kit ligand, stem cell factor, promotes mast cell survival by suppressing apoptosis. Am J Pathol 1994 1.53
39 Unequivocal delayed hypersensitivity in mast cell-deficient and beige mice. Science 1984 1.53
40 Ultrastructural identification of the mouse basophil. Blood 1982 1.47
41 Substance P-induced augmentation of cutaneous vascular permeability and granulocyte infiltration in mice is mast cell dependent. J Clin Invest 1989 1.47
42 IgE enhances Fc epsilon receptor I expression and IgE-dependent release of histamine and lipid mediators from human umbilical cord blood-derived mast cells: synergistic effect of IL-4 and IgE on human mast cell Fc epsilon receptor I expression and mediator release. J Immunol 1999 1.45
43 Ablation of immunity to Amblyomma americanum by anti-basophil serum: cooperation between basophils and eosinophils in expression of immunity to ectoparasites (ticks) in guinea pigs. J Immunol 1982 1.45
44 Development of large numbers of mast cells at sites of idiopathic chronic dermatitis in genetically mast cell-deficient WBB6F1-W/Wv mice. Blood 1987 1.43
45 Effects of chronic treatment with the c-kit ligand, stem cell factor, on immunoglobulin E-dependent anaphylaxis in mice. Genetically mast cell-deficient Sl/Sld mice acquire anaphylactic responsiveness, but the congenic normal mice do not exhibit augmented responses. J Clin Invest 1993 1.43
46 Regulation of mouse peritoneal mast cell secretory function by stem cell factor, IL-3 or IL-4. J Immunol 1993 1.38
47 Immediate and late inflammatory responses to ragweed antigen challenge of the peripheral airways in allergic asthmatics. Cellular, mediator, and permeability changes. Am Rev Respir Dis 1991 1.38
48 IgE regulates mouse basophil Fc epsilon RI expression in vivo. J Immunol 1997 1.38
49 Cellular and vascular manifestations of cell-mediated immunity. Hum Pathol 1986 1.37
50 The rat c-kit ligand, stem cell factor, induces c-kit receptor-dependent mouse mast cell activation in vivo. Evidence that signaling through the c-kit receptor can induce expression of cellular function. J Exp Med 1992 1.35
51 Effects of stem cell factor (kit-ligand) and interleukin-3 on the growth and serine proteinase expression of rat bone-marrow-derived or serosal mast cells. Blood 1994 1.35
52 Microvascular heparin-like species with anticoagulant activity. Am J Physiol 1983 1.34
53 Lipid bodies: cytoplasmic organelles important to arachidonate metabolism in macrophages and mast cells. J Immunol 1983 1.33
54 Role of mast cells in ion transport abnormalities associated with intestinal anaphylaxis. Correction of the diminished secretory response in genetically mast cell-deficient W/Wv mice by bone marrow transplantation. J Clin Invest 1991 1.31
55 Phenotypic changes of bone marrow-derived mast cells after intraperitoneal transfer into W/Wv mice that are genetically deficient in mast cells. J Exp Med 1987 1.29
56 Recombinant human stem cell factor (kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivo. J Exp Med 1996 1.27
57 Mast cell activation enhances airway responsiveness to methacholine in the mouse. J Clin Invest 1993 1.26
58 Impaired mast cell development and innate immunity in Mac-1 (CD11b/CD18, CR3)-deficient mice. J Immunol 1998 1.25
59 The two faces of the mast cell. Nature 1996 1.25
60 Eosinophils from patients with blood eosinophilia express transforming growth factor beta 1. Blood 1991 1.24
61 Human eosinophils can express the cytokines tumor necrosis factor-alpha and macrophage inflammatory protein-1 alpha. J Clin Invest 1993 1.23
62 Activation of MAP kinases, pp90rsk and pp70-S6 kinases in mouse mast cells by signaling through the c-kit receptor tyrosine kinase or Fc epsilon RI: rapamycin inhibits activation of pp70-S6 kinase and proliferation in mouse mast cells. Eur J Immunol 1993 1.19
63 The c-kit ligand, stem cell factor, can enhance innate immunity through effects on mast cells. J Exp Med 1998 1.19
64 In vivo immunological function of mast cells derived from embryonic stem cells: an approach for the rapid analysis of even embryonic lethal mutations in adult mice in vivo. Proc Natl Acad Sci U S A 2000 1.18
65 Promotion of mouse fibroblast collagen gene expression by mast cells stimulated via the Fc epsilon RI. Role for mast cell-derived transforming growth factor beta and tumor necrosis factor alpha. J Exp Med 1994 1.18
66 Negative regulation of Fc epsilon RI-mediated degranulation by CD81. J Exp Med 1997 1.18
67 Differential release of mast cell interleukin-6 via c-kit. Blood 1997 1.15
68 Basophil and mast cell degranulation: ultrastructural analysis of mechanisms of mediator release. Fed Proc 1983 1.15
69 Phorbol 12-myristate 13-acetate-induced development of functionally active mast cells in W/Wv but not Sl/Sld genetically mast cell-deficient mice. Blood 1990 1.15
70 Ultrastructural immunogold localization of tumor necrosis factor-alpha to the matrix compartment of eosinophil secondary granules in patients with idiopathic hypereosinophilic syndrome. J Histochem Cytochem 1993 1.14
71 Anaphylactic degranulation of guinea pig basophilic leukocytes. I. Fusion of granule membranes and cytoplasmic vesicles formation and resolution of degranulation sacs. Lab Invest 1981 1.13
72 Vesicular uptake of eosinophil peroxidase by guinea pig basophils and by cloned mouse mast cells and granule-containing lymphoid cells. Am J Pathol 1985 1.13
73 Spontaneous canine mast cell tumors express tandem duplications in the proto-oncogene c-kit. Exp Hematol 1999 1.13
74 Effects of interleukin-3 with or without the c-kit ligand, stem cell factor, on the survival and cytoplasmic granule formation of mouse basophils and mast cells in vitro. Am J Pathol 1994 1.13
75 Differences in the expression of the cardiopulmonary alterations associated with anti-immunoglobulin E-induced or active anaphylaxis in mast cell-deficient and normal mice. Mast cells are not required for the cardiopulmonary changes associated with certain fatal anaphylactic responses. J Clin Invest 1991 1.12
76 Cloned mouse cells with natural killer function and cloned suppressor T cells express ultrastructural and biochemical features not shared by cloned inducer T cells. J Exp Med 1983 1.10
77 The cells of the allergic response: mast cells, basophils, and eosinophils. JAMA 1997 1.09
78 Stem cell factor (SCF), a novel hematopoietic growth factor and ligand for c-kit tyrosine kinase receptor, maps on human chromosome 12 between 12q14.3 and 12qter. Somat Cell Mol Genet 1991 1.08
79 Evidence for a vesicular transport mechanism in guinea pig basophilic leukocytes. Lab Invest 1980 1.07
80 Cloned LYT-2+ cytolytic T lymphocytes destroy allogeneic tissue in vivo. J Exp Med 1984 1.07
81 Multiple bidirectional alterations of phenotype and changes in proliferative potential during the in vitro and in vivo passage of clonal mast cell populations derived from mouse peritoneal mast cells. Blood 1988 1.06
82 Anatomical variation in mast cell nerve associations in the rat small intestine, heart, lung, and skin. Similarities of distances between neural processes and mast cells, eosinophils, or plasma cells in the jejunal lamina propria. Lab Invest 1990 1.06
83 Stem cell factor contributes to intestinal mucosal mast cell hyperplasia in rats infected with Nippostrongylus brasiliensis or Trichinella spiralis, but anti-stem cell factor treatment decreases parasite egg production during N brasiliensis infection. Blood 1995 1.05
84 Ultrastructural immunogold localization of subcellular sites of TNF-alpha in colonic Crohn's disease. J Leukoc Biol 1995 1.04
85 Genetic analysis reveals cell type-specific regulation of receptor tyrosine kinase c-Kit by the protein tyrosine phosphatase SHP1. J Exp Med 1996 1.04
86 Tumor-basophil interactions in vitro--a scanning and transmission electron microscopic study. J Immunol 1979 1.03
87 Sulfated glycosaminoglycans of guinea pig basophilic leukocytes. J Immunol 1978 1.03
88 Detection of mouse mast cell-associated protease mRNA. Heparinase treatment greatly improves RT-PCR of tissues containing mast cell heparin. Am J Pathol 1995 1.02
89 Reevaluation of reserpine-induced suppression of contact sensitivity. Evidence that reserpine interferes with T lymphocyte function independently of an effect on mast cells. J Exp Med 1985 1.01
90 Anticoagulantly active heparin-like molecules from mast cell-deficient mice. Am J Physiol 1986 1.01
91 Mast cells contribute to the changes in heart rate, but not hypotension or death, associated with active anaphylaxis in mice. J Immunol 1993 1.00
92 Substance P induces ion secretion in mouse small intestine through effects on enteric nerves and mast cells. Am J Physiol 1995 1.00
93 Basophil influx occurs after nasal antigen challenge: effects of topical corticosteroid pretreatment. J Allergy Clin Immunol 1988 0.99
94 Undiminished immunologic tolerance to contact sensitivity in mast cell-deficient W/Wv and Sl/Sld mice. J Immunol 1985 0.99
95 A role for CD21/CD35 and CD19 in responses to acute septic peritonitis: a potential mechanism for mast cell activation. J Immunol 2000 0.99
96 Lack of TGF-alpha and TGF-beta 1 synthesis by human eosinophils in chronic oral ulcers. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996 0.99
97 Expression of stem cell factor receptor (c-kit) by the malignant mast cells from spontaneous canine mast cell tumours. J Comp Pathol 1996 0.97
98 What do mast cells have to do with delayed hypersensitivity? Lab Invest 1984 0.97
99 Dexamethasone or cyclosporin A suppress mast cell-leukocyte cytokine cascades. Multiple mechanisms of inhibition of IgE- and mast cell-dependent cutaneous inflammation in the mouse. J Immunol 1995 0.97
100 Mast cells and basophils in acquired immunity. Br Med Bull 2000 0.97
101 Production of macrophage inflammatory protein-1alpha by human mast cells: increased anti-IgE-dependent secretion after IgE-dependent enhancement of mast cell IgE-binding ability. Lab Invest 1997 0.97
102 Metabolic studies of guinea pig basophilic leukocytes in short-term tissue culture. I. Measurement of histaminesynthesizing capacity by using an isotopic-thin layer chromatographic assay. J Immunol 1976 0.96
103 Production of transforming growth factor alpha by hamster eosinophils. Am J Pathol 1990 0.96
104 New approaches for the analysis of mast cell maturation, heterogeneity, and function. Fed Proc 1987 0.95
105 A cloned cell with NK function resembles basophils by ultrastructure and expresses IgE receptors. Nature 1982 0.95
106 Involvement of interleukin-3 in delayed-type hypersensitivity. Blood 1998 0.95
107 Differences in the volume distributions of human lung mast cell granules and lipid bodies: evidence that the size of these organelles is regulated by distinct mechanisms. J Cell Biol 1985 0.95
108 Studies of the role of mast cells in contact sensitivity responses. Passive transfer of the reaction into mast cell-deficient mice locally reconstituted with cultured mast cells: effect of reserpine on transfer of the reaction with DNP-specific cloned T cells. Cell Immunol 1987 0.94
109 Expression of functional TrkA receptor tyrosine kinase in the HMC-1 human mast cell line and in human mast cells. Blood 1997 0.94
110 Malignant fibrous histiocytoma and pleomorphic sarcoma in association with medullary bone infarcts. Cancer 1978 0.94
111 The microvasculature is the critical target of the immune response in vascularized skin allograft rejection. J Invest Dermatol 1980 0.93
112 Stem-cell factor, the kit ligand, induces direct degranulation of rat peritoneal mast cells in vitro and in vivo: dependence of the in vitro effect on period of culture and comparisons of stem-cell factor with other mast cell-activating agents. Immunology 1995 0.93
113 Neovascularization and coronary atherosclerotic plaque: cinematographic localization and quantitative histologic analysis. Hum Pathol 1987 0.93
114 Antigen-induced, IgE-mediated degranulation of cloned immature mast cells derived from normal mice. Am J Pathol 1987 0.92
115 Cloning and functional analysis of the mouse c-kit promoter. Biochem Biophys Res Commun 1993 0.92
116 Mouse mast cell clones: modulation of functional maturity in vitro. Monogr Allergy 1983 0.92
117 Piecemeal degranulation of mast cells in the inflammatory eyelid lesions of interleukin-4 transgenic mice. Evidence of mast cell histamine release in vivo by diamine oxidase-gold enzyme-affinity ultrastructural cytochemistry. Blood 1994 0.91
118 Ultrastructure of human basophils developing in vitro. Evidence for the acquisition of peroxidase by basophils and for different effects of human and murine growth factors on human basophil and eosinophil maturation. Lab Invest 1985 0.91
119 Distinct patterns of early response gene expression and proliferation in mouse mast cells stimulated by stem cell factor, interleukin-3, or IgE and antigen. Eur J Immunol 1993 0.90
120 Ultrastructural criteria for identification of mast cells and basophils in humans, guinea pigs, and mice. Am Rev Respir Dis 1983 0.90
121 Identification of IgE-bearing cells in the late-phase response to antigen in the lung as basophils. Am J Respir Cell Mol Biol 1994 0.89
122 Dexamethasone and cyclosporin A suppress mast cell-leukocyte cytokine cascades by multiple mechanisms. Int Arch Allergy Immunol 1995 0.88
123 Tissue destruction resulting from the interaction of cytotoxic T cells and their targets. Ann N Y Acad Sci 1988 0.88
124 Stem cell factor enhances immunoglobulin E-dependent mediator release from cultured rat bone marrow-derived mast cells: activation of previously unresponsive cells demonstrated by a novel ELISPOT assay. Immunology 1996 0.88
125 Expression of transforming growth factors-alpha and beta 1 messenger RNA and product by eosinophils in nasal polyps. J Allergy Clin Immunol 1994 0.88
126 Intestinal adaptation after extensive resection of the small intestine and prolonged administration of parenteral nutrition. Surg Gynecol Obstet 1976 0.87
127 Cytoplasmic granule formation in mouse pancreatic acinar cells. Evidence for formation of immature granules (condensing vacuoles) by aggregation and fusion of progranules of unit size, and for reductions in membrane surface area and immature granule volume during granule maturation. Cell Tissue Res 1994 0.87
128 A role for Bax in the regulation of apoptosis in mouse mast cells. J Invest Dermatol 2000 0.86
129 Expression of cell-mediated hypersensitivity in vivo--recent advances. Int Rev Exp Pathol 1980 0.86
130 Mast cells augment lesion size and persistence during experimental Leishmania major infection in the mouse. J Immunol 1994 0.86
131 Salivary EGF regulates eosinophil-derived TGF-alpha expression in hamster oral wounds. Am J Physiol 1996 0.86
132 Preparation of a rabbit anti-guinea pig basophil serum: in vitro and in vivo characterization. J Immunol 1978 0.86
133 Regulation of mouse mast cell surface Fc epsilon RI expression by dexamethasone. Int Immunol 2001 0.85
134 Recurrent gastrointestinal bleeding associated with myelofibrosis and diffuse intestinal telangiectasias. Gastroenterology 1991 0.85
135 Ethanol-induced acute gastric injury in mast cell-deficient and congenic normal mice. Evidence that mast cells can augment the area of damage. Am J Pathol 1987 0.85
136 The analysis of mast cell function in vivo using mast cell-deficient mice. Adv Exp Med Biol 1994 0.85
137 125I-fibrin deposition in contact sensitivity reactions in the mouse. Sensitivity of the assay for quantitating reactions after active or passive sensitization. J Immunol 1986 0.84
138 The regulation of tumor necrosis factor-alpha production in murine mast cells: pentoxifylline or dexamethasone inhibits IgE-dependent production of TNF-alpha by distinct mechanisms. Cell Immunol 1996 0.84
139 Rat bone marrow-derived mast cells co-cultured with 3T3 fibroblasts in the absence of T-cell derived cytokines require stem cell factor for their survival and maintain their mucosal mast cell-like phenotype. Immunology 1996 0.84
140 Mast cells are not required for anaphylatoxin-induced ileal smooth muscle contraction. J Immunol 1987 0.83
141 Ultrastructural immunogold localization of tumor necrosis factor-alpha to the cytoplasmic granules of rat peritoneal mast cells with rapid microwave fixation. J Allergy Clin Immunol 1994 0.83
142 Mast-cell heparin demystified. Nature 1999 0.83
143 Defective cytoplasmic granule formation. I. Abnormalities affecting tissue mast cells and pancreatic acinar cells of beige mice. Lab Invest 1987 0.83
144 Promotion of mouse fibroblast proliferation by IgE-dependent activation of mouse mast cells: role for mast cell tumor necrosis factor-alpha and transforming growth factor-beta 1. J Allergy Clin Immunol 1997 0.82
145 Mast cells in rat dermis and jejunal lamina propria show a five-fold difference in unit granule volume. Cell Tissue Res 1991 0.82
146 Mast cell activation is not required for induction of airway hyperresponsiveness by ozone in mice. J Appl Physiol (1985) 1999 0.82
147 Histamine-releasing activity (HRA). III. HRA induces human basophil histamine release by provoking noncytotoxic granule exocytosis. Clin Immunol Immunopathol 1984 0.81
148 Ultrastructural characteristics of Fc epsilon R-positive basophils in the spleen and bone marrow of mice immunized with goat anti-mouse IgD antibody. Lab Invest 1993 0.81
149 Defective cytoplasmic granule formation.II. Differences in patterns of radiolabeling of secretory granules in beige versus normal mouse pancreatic acinar cells after [3H]glycine administration in vivo. Cell Tissue Res 1998 0.81
150 TNF alpha is important in human lung allergic reactions. Am J Respir Cell Mol Biol 1996 0.81
151 Variants of vasoactive intestinal peptide in mouse mast cells and rat basophilic leukemia cells. Cell Immunol 1993 0.81
152 [125I]fibrin deposition occurs at both early and late intervals of IgE-dependent or contact sensitivity reactions elicited in mouse skin. Mast cell-dependent augmentation of fibrin deposition at early intervals in combined IgE-dependent and contact sensitivity reactions. J Immunol 1990 0.81
153 Lack of detectable immunoglobulin E receptor expression on 33 of 34 cell lines with natural killer-like or cytotoxic-T-lymphocyte activity. Cell Immunol 1985 0.80
154 Cloned mouse mast cells and normal mouse peritoneal mast cells. Determination of serotonin content and ability to synthesize serotonin in vitro. Int Arch Allergy Appl Immunol 1985 0.79
155 Dexamethasone or cyclosporin A inhibits stem cell factor-dependent secretory responses of rat peritoneal mast cells in vitro. Immunopharmacology 1996 0.79
156 Gastrointestinal mast cells. New approaches for analyzing their function in vivo. Gastroenterol Clin North Am 1991 0.79
157 Rapid microwave fixation of rat mast cells. I. Localization of granule chymase with an ultrastructural postembedding immunogold technique. Lab Invest 1987 0.79
158 Anaphylactic degranulation of guinea pig basophilic leukocytes. II. Evidence for regranulation of mature basophils during recovery from degranulation in vitro. Lab Invest 1982 0.79
159 Augmentation of interleukin-2 production after cardiac operations in patients treated with erythropoietin. J Thorac Cardiovasc Surg 1992 0.79
160 Mast cells contribute to PACAP-induced dermal oedema in mice. Regul Pept 1999 0.78
161 Global Allergy Forum and Second Davos Declaration 2013 Allergy: Barriers to cure--challenges and actions to be taken. Allergy 2014 0.78
162 Inhibition of cutaneous contact hypersensitivity in the mouse with systemic or topical spiperone: topical application of spiperone produces local immunosuppression without inducing systemic neuroleptic effects. J Invest Dermatol 1992 0.78
163 The HMC-1 human mast cell line expresses the hepatocyte growth factor receptor c-met. Biochem Biophys Res Commun 1997 0.77
164 Tumor necrosis factor alpha immunoreactivity of rat peritoneal mast cell granules decreases during early secretion induced by compound 48/80: an ultrastructural immunogold morphometric analysis. Int Arch Allergy Immunol 1996 0.77
165 Stem cell factor influences neuro-immune interactions: the response of mast cells to pituitary adenylate cyclase activating polypeptide is altered by stem cell factor. Regul Pept 1999 0.77
166 Immunocytochemical localization of histamine in secretory granules of rat peritoneal mast cells with conventional or rapid microwave fixation and an ultrastructural post-embedding immunogold technique. J Histochem Cytochem 1992 0.77
167 Nonspecific esterase activity expressed in Weibel-Palade bodies of cloned guinea pig aortic endothelial cells. J Histochem Cytochem 1987 0.77
168 Ultrastructure of human dermal mast cells in 29 different lysosomal storage diseases. Virchows Arch B Cell Pathol Incl Mol Pathol 1993 0.77
169 Induction of local inflammation by recombinant human platelet factor 4 in the mouse. Cell Immunol 1991 0.76
170 Surface membrane traffic in guinea pig basophils exposed to cationic ferritin. Int Arch Allergy Appl Immunol 1985 0.76
171 Beige mouse mast cells generated in vitro: ultrastructural analysis of maturation induced by sodium butyrate and of IgE-mediated, antigen-dependent degranulation. Int Arch Allergy Appl Immunol 1987 0.76
172 Mast cell abnormalities in the Chédiak-Higashi syndrome. Int Arch Allergy Immunol 1993 0.75
173 Uncertainty of histologic classification of experimental tumors. Science 1984 0.75
174 Analysis of mast cell activation using diamine oxidase-gold enzyme-affinity ultrastructural cytochemistry. Int Arch Allergy Immunol 1995 0.75
175 Glycosaminoglycans and proteases of guinea pig basophilic leukocytes. Kroc Found Ser 1981 0.75
176 P- and E-selectins are required for the leukocyte recruitment, but not the tissue swelling, associated with IgE- and mast cell-dependent inflammation in mouse skin. Lab Invest 1998 0.75
177 The murine immune lymphocyte transfer reaction revisited. Transplant Proc 1991 0.75
178 Experiments on the mode of action of piriprost (U-60,257), an inhibitor of leukotriene formation in cloned mouse mast cells and in rat basophil leukemia cells. Biochem Pharmacol 1987 0.75
179 Surface membrane alterations in guinea pig basophils undergoing anaphylactic degranulation. A scanning electron microscopic study. Lab Invest 1981 0.75
180 Cloned "anomalous" killer cells derived from allogeneic mixed leukocyte culture. Cell Immunol 1987 0.75
181 Generation and recognition of vasoactive intestinal peptide by cells of the immune system. Ann N Y Acad Sci 1990 0.75
182 Inbred guinea pig aortic endothelial cell clones. Model for studying the vascular endothelium under totally isologous conditions. Lab Invest 1986 0.75
183 The surface antigenicity of serially transplantable malignant human lymphoid cells derived from subjects with infectious mononucleosis, Hodgkin's disease, chronic lymphatic leukemia, or acute lymphoblastic leukemia. Cancer Res 1974 0.75
184 A simple technique to facilitate the ultrastructural analysis of cells in soft agar culture systems: demonstration of the development in vitro of morphologically mature mast cells and phagocytic macrophages from the bone marrow cells of genetically mast cell-deficient W/Wv or congenic normal mice. Lab Invest 1990 0.75
185 Mouse mast cells and other granulated leukocyte clones. Ultrastructure of cloned mouse leukocytes. Monogr Allergy 1983 0.75
186 A role for cytoplasmic vesicles in anaphylactic degranulation of guinea pig basophils. Int Arch Allergy Appl Immunol 1981 0.75
187 Patients without basophils. Lancet 1977 0.75
188 Analysis of mast cell function in biological responses not involving IgE. Int Arch Allergy Appl Immunol 1987 0.75
189 Plasminogen activator of guinea pig basophils. A protease probably localized to the cell surface. Monogr Allergy 1979 0.75
190 Ultrastructural cytochemical and autoradiographic demonstration of nonspecific esterase(s) in guinea pig basophils. J Histochem Cytochem 1987 0.75
191 Bystander suppression of tumor growth: evidence that specific targets and bystanders are damaged by injury to a common microvasculature. J Immunol 1982 0.75
192 Ultrastructural analysis of human skin biopsy specimens from patients receiving recombinant human stem cell factor: subcutaneous injection of rhSCF induces dermal mast cell degranulation and granulocyte recruitment at the injection site. J Allergy Clin Immunol 1998 0.75
193 Guinea pig basophil morphology in vitro. I. Ultrastructure of uropod-bearing (motile) basophils and modulation of motile structures by serum and substrate effects. J Immunol 1981 0.75
194 Alterations in arachidonic acid metabolism in mouse mast cells induced to undergo maturation in vitro in response to stem cell factor. J Allergy Clin Immunol 1996 0.75
195 Diamine oxidase-gold ultrastructural localization of histamine in human skin biopsies containing mast cells stimulated to degranulate in vivo by exposure to recombinant human stem cell factor. Blood 1997 0.75